IFP Advisors Inc raised its position in Cronos Group Inc (NASDAQ:CRON) by 400.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,260 shares of the company’s stock after purchasing an additional 11,412 shares during the quarter. IFP Advisors Inc’s holdings in Cronos Group were worth $159,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Exane Derivatives acquired a new stake in Cronos Group during the third quarter worth approximately $123,000. CenterStar Asset Management LLC acquired a new stake in Cronos Group during the third quarter worth approximately $166,000. Tower Research Capital LLC TRC grew its stake in Cronos Group by 10,393.4% during the second quarter. Tower Research Capital LLC TRC now owns 17,419 shares of the company’s stock worth $114,000 after purchasing an additional 17,253 shares during the period. Gerber Kawasaki Wealth & Investment Management acquired a new stake in Cronos Group during the second quarter worth approximately $129,000. Finally, Royal Bank of Canada acquired a new stake in Cronos Group during the first quarter worth approximately $169,000. Hedge funds and other institutional investors own 9.77% of the company’s stock.

Several equities research analysts recently commented on the company. Canaccord Genuity raised Cronos Group from a “sell” rating to a “hold” rating in a research note on Wednesday, August 15th. Zacks Investment Research raised Cronos Group from a “hold” rating to a “buy” rating and set a $9.25 target price for the company in a research note on Tuesday. Finally, Cann assumed coverage on Cronos Group in a research note on Friday, October 12th. They set a “sell” rating and a $4.50 target price for the company. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $6.88.

NASDAQ CRON opened at $8.55 on Friday. Cronos Group Inc has a one year low of $2.52 and a one year high of $15.30. The company has a market cap of $1.74 billion and a P/E ratio of 855.00. The company has a quick ratio of 44.71, a current ratio of 52.98 and a debt-to-equity ratio of 0.02.

COPYRIGHT VIOLATION WARNING: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2018/11/10/ifp-advisors-inc-boosts-holdings-in-cronos-group-inc-cron.html.

Cronos Group Company Profile

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

See Also: What is the NASDAQ?

Want to see what other hedge funds are holding CRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cronos Group Inc (NASDAQ:CRON).

Institutional Ownership by Quarter for Cronos Group (NASDAQ:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.